Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
03/21/1991 | WO1991000856A3 (1,2n) and (3,2n)-carbocyclic-2-amino tetralin derivatives |
03/21/1991 | DE3930392A1 Use of xanthine derivs. to reduce nephrotoxicity |
03/21/1991 | DE3930193A1 Agent for suppressing odour - contg. lower acylated deriv. of mono-glyceride of higher unbranched mono-carboxylic acid as deodorant |
03/21/1991 | DE3930130A1 Neue amidingruppen-haltige diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel New amidine-containing diphosphonic acid derivatives, process for their production and pharmaceutical compositions containing them |
03/21/1991 | CA2066172A1 Method for producing soluble glucans |
03/21/1991 | CA2025744A1 13-bromo-and 13,14-dibromoergolines, their production and use in medicinal agents |
03/21/1991 | CA2025719A1 Method of treatment & heterocyclic compounds used therein |
03/20/1991 | EP0418153A1 Preparation of lipidic microparticles |
03/20/1991 | EP0418143A1 Dicarboxylic acids derivatives containing a nitrogen or oxygen heteroring, process for their preparation and their use as medicines |
03/20/1991 | EP0418128A1 System for continuously delivering vitamin A in feedwater |
03/20/1991 | EP0418110A1 Use of anticomplemental agents for the treatment of parodontoses |
03/20/1991 | EP0418071A2 New N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase |
03/20/1991 | EP0418065A2 Dihydrocaffeic acid derivatives, use thereof for medical treatments and pharmaceutical preparations containing same |
03/20/1991 | EP0418043A1 Non-effervescent ibuprofen compositions |
03/20/1991 | EP0418020A2 Cephalosporinderivatives, process for their preparation and pharmaceutical compositions |
03/20/1991 | EP0418007A2 Cyclopentane derivatives |
03/20/1991 | EP0418004A2 Preventive and therapeutic agent for hepatitis |
03/20/1991 | EP0417999A1 Antiviral compounds |
03/20/1991 | EP0417941A2 Use of a cyanine dye in an antitumor agent |
03/20/1991 | EP0417870A2 Chelates for complexation of radioactive isotopes, their metal complexes and their use in diagnosis and therapy |
03/20/1991 | EP0417840A1 Antiviral tetrahydroimidazo [1,4]-benzodiazepines |
03/20/1991 | EP0417790A2 S-triazolo[3,4-i]purine derivatives |
03/20/1991 | EP0417772A2 Composition for external application |
03/20/1991 | EP0417760A2 Phenylalkanoyl substituted imidazo[4,5-c] pyridines |
03/20/1991 | EP0417751A2 New thiazole derivatives, processes for the preparation thereof and pharmaceutical compositon comprising the same |
03/20/1991 | EP0417746A2 N-Azabicyclo/3.3.0/octane amides of aromatic acids |
03/20/1991 | EP0417745A2 Heteroaryl substituted imidazo [4,5-c] pyridines |
03/20/1991 | EP0417725A2 Bile-acid derivatives, a process for their production and their use as medicines |
03/20/1991 | EP0417721A2 Novel peptidase and isomerase inhibitors |
03/20/1991 | EP0417698A2 Amino acid derivatives having renin-inhibiting activity, process for their preparation, agents containing them, and their use |
03/20/1991 | EP0417671A2 3,4,5,6-Tetrahydro-2H-1,7,4-Benzodioxazonines as cardiovascular agents |
03/20/1991 | EP0417669A2 Pyridinyl-quinolone compounds, their preparation and use |
03/20/1991 | EP0417653A1 3-(1-Substituted-4-piperazinyl)-1H-indazoles, a process for their preparation and their use as medicaments |
03/20/1991 | EP0417637A2 Use of dopamine autoreceptor agonists in the treatment of drug dependency |
03/20/1991 | EP0417631A2 Condensed diazepinones, process for their preparation, and medicaments containing these compounds |
03/20/1991 | EP0417630A2 Condensed diazepinones, process for their preparation, and medicaments containing these compounds |
03/20/1991 | EP0417604A2 Process for preparing riboflavin-5'-phosphate and its sodium salt |
03/20/1991 | EP0417584A2 N-substituted-4-pyrimidinamines and -pyrimidindiamines, a process for their preparation and their use as medicaments |
03/20/1991 | EP0417560A1 Antiviral compounds |
03/20/1991 | EP0417534A1 Pyrido[2,3-b][1,4]benzoxazepin (and thiazepin)-6(5H)-ones and thiones and their use in the prevention or treatment of AIDS |
03/20/1991 | EP0417496A2 Transdermal nitroglycerin patch with penetration enhancers |
03/20/1991 | EP0417449A1 Arylpyrazole derivatives as platelet aggregation inhibitors |
03/20/1991 | EP0417385A2 Preventive and curative medicament against infection with influenza virus, containing tea or tea polyphenols |
03/20/1991 | EP0417281A1 COMPOSITION CONTAINING 5$g(a)-DIHYDRO-19-NORETHYSTERONE AND ITS DERIVATIVES CAPABLE OF INHIBITING AROMATASE IN VIVO |
03/20/1991 | EP0417245A1 Topical analgesic composition |
03/20/1991 | EP0417209A1 Compositions and methods for administering therapeutically active compounds |
03/20/1991 | EP0417188A1 Protein crosslinking reagents cleavable within acidified intracellular vesicles |
03/20/1991 | EP0417143A1 Cyclic lactams for cholesterol and atherosclerosis control |
03/20/1991 | EP0417113A1 Preparation of carbamic acid ester for the treatment of addiction to alcohol |
03/20/1991 | EP0417104A1 Perfluorochemical emulsion with stabilized vesicles |
03/20/1991 | EP0406307A4 Water soluble ibuprofen compositions and methods of making them |
03/20/1991 | EP0341264A4 Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction) |
03/20/1991 | EP0226588B1 Process for preparation of a solid form for oral use based on nifedipine with controlled release of the active substance |
03/20/1991 | CN1050023A Process for preparation of cephalosporin derivative |
03/20/1991 | CN1050022A Process for preparing dehydrocycloclausenamide derivatives |
03/20/1991 | CN1050021A Synthetic process of diterpenic lactone |
03/20/1991 | CN1050018A Benzoylguanidine, process for preparing same, their use as medicine and medicine containing same |
03/20/1991 | CN1049973A Pharmaceutical composition having antitumor activity and preparation for its manufacture |
03/20/1991 | CN1049971A Specific itch-stopping dew and its preparation |
03/20/1991 | CN1012064B Preparation of quinoline carboxylic acid |
03/20/1991 | CA2025471A1 Additional further novel aklanophenones |
03/20/1991 | CA2025470A1 Further novel alkanophenones |
03/20/1991 | CA2023813A1 Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4 - tetrahydroquinolinyl group having retinoid-like activity |
03/20/1991 | CA2023812A1 Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4 - tetrahydroquinolinyl group having retinoid-like activity |
03/19/1991 | WO1991004031A1 Oral anticoagulant/platelet inhibitor low dose formulation |
03/19/1991 | US5001282 Method of treating diabetes mellitus with bisphenol derivatives |
03/19/1991 | US5001276 Novel tetrahydronaphthalene and indane derivatives |
03/19/1991 | US5001258 Antibiotic, fumifungin, a microbial process for the preparation thereof, and the use thereof as a pharmaceutical |
03/19/1991 | US5001241 3-KETO HMG-CoA reductase inhibitors |
03/19/1991 | US5001236 Benzothiazepines |
03/19/1991 | US5001235 Antibiotic beta-lactams containing a pyridone carboxylic acid or acid derivative |
03/19/1991 | US5001162 Use of avarone for the control of adult T-cell leukemia/lymphoma |
03/19/1991 | US5001161 Pharmaceutical composition comprising metroprolol succinate |
03/19/1991 | US5001160 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders |
03/19/1991 | US5001159 N-aminobutyl-n-phenylarylamide compounds and their application in therapy |
03/19/1991 | US5001158 Nitrosoureas compounds preparation thereof and utilization thereof in anticancerous |
03/19/1991 | US5001156 Lipophilic quaternary ammonium salicylates, their use in cosmetics and in dermopharmacy |
03/19/1991 | US5001155 β-ionone derivative as antifungal agent |
03/19/1991 | US5001154 5-keto prostaglandin e |
03/19/1991 | US5001153 Ocular hypotensive agents |
03/19/1991 | US5001152 Use of catechol-O-methyl transferase (COMT) inhibitors and their physiologically acceptable salts for ulcer treatment |
03/19/1991 | US5001151 Aqueous nitroglycerin injection and manufacturing process |
03/19/1991 | US5001148 Mevinic acid derivatives |
03/19/1991 | US5001147 Photochemotherapic method of treating psoriasis by using methylangelicin compounds |
03/19/1991 | US5001145 Macrolide compounds |
03/19/1991 | US5001143 Pharmaceutical composition for prophylactic and preventive of ketosis of livestocks |
03/19/1991 | US5001142 Alzheimer's disease |
03/19/1991 | US5001141 N-(2-(2-oxo-1-imidazolidinyl)ethyl)-3-phenyl-urea and analogs as agents for induction of antioxidant enzymes |
03/19/1991 | US5001139 Enchancers for the transdermal flux of nivadipine |
03/19/1991 | US5001135 Indole derivatives |
03/19/1991 | US5001134 Piperidines, processes of preparation and medications containing them |
03/19/1991 | US5001132 Phenyloxypropanolamine derivatives and their application in therapeutics |
03/19/1991 | US5001130 Psychotropic heterobicycloalkylpiperazine derivatives |
03/19/1991 | US5001127 4-substituted pyrazolo[3,4-d]pyrimidine derivatives |
03/19/1991 | US5001125 Anti-virally active pyridazinamines |
03/19/1991 | US5001124 4-isoxazolecarboxamide derivatives |
03/19/1991 | US5001123 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists |
03/19/1991 | US5001122 Use of diazepinones for treating disorders of the microcirculation |
03/19/1991 | US5001118 Method for preventing senescence and increasing bone mass |
03/19/1991 | US5001117 Use of lecithin to restore olfaction and taste |